Cargando…
Development of activated endothelial targeted high-density lipoprotein nanoparticles
Endothelial inflammation is an important pathophysiological driving force in various acute and chronic inflammatory diseases. High-density lipoproteins (HDLs) play critical roles in regulating endothelial functions and resolving endothelial inflammation. In the present study, we developed synthetic...
Autores principales: | Yu, Minzhi, Hong, Kristen, Adili, Reheman, Mei, Ling, Liu, Lisha, He, Hongliang, Guo, Yanhong, Chen, Y. Eugene, Holinstat, Michael, Schwendeman, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464908/ https://www.ncbi.nlm.nih.gov/pubmed/36105190 http://dx.doi.org/10.3389/fphar.2022.902269 |
Ejemplares similares
-
Synthetic high-density lipoproteins loaded with an antiplatelet drug for efficient inhibition of thrombosis in mice
por: He, Hongliang, et al.
Publicado: (2020) -
Evaluation of receptor‐ligand mechanisms of dual‐targeted particles to an inflamed endothelium
por: Fromen, Catherine A., et al.
Publicado: (2016) -
Synergetic Effect of rHDL and LXR Agonist on Reduction of Atherosclerosis in Mice
por: Morin, Emily E., et al.
Publicado: (2020) -
Attenuating lipid metabolism in atherosclerosis: The potential role of Anti-oxidative effects on low-density lipoprotein of herbal medicines
por: Duan, Huxinyue, et al.
Publicado: (2023) -
Synthetic High-Density Lipoprotein-Mediated Targeted Delivery of Liver X Receptors Agonist Promotes Atherosclerosis Regression
por: Guo, Yanhong, et al.
Publicado: (2017)